CS
NVLN

Credit Suisse’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Credit Suisse’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
2017
Q3 		$225K Buy
2017
Q2 		$228K Buy
2017
Q1 		$233K Sell
2016
Q4 		$239K Buy